In the course of our screening program for unique microbial products with pharmacological activity, we have isolated sporostatin (M5032, 1) as a new inhibitor of cyclic adenosine 3',5'-rnonophosphate phosphodiesterase (CAMP-PDE) from the fermentation filtrate of Sporormiella sp. M5032 (FERM P-9506)1). In this paper,
we describe the purification, physicochemical properties, structural elucidation and biological properties of sporostatin (1) .
Materials and Methods

General Procedure
The IR spectrum was taken with a Hitachi 260-50 IR spectrophotometer. The UVspectrum was recorded on a Shimadzu UV-365 spectrometer. The NMRspectra were obtained with a Jeol JNM-GSX400 spectrometer at 400MHz CH) and 100MHz (13C) with TMS as an internal reference. The mass spectrum was taken with a Jeol JMS-SX102 spectrometer.
Materials
Cyclic adenosine 3',5'-monophosphate phosphodiesterase (CAMP-PDE) from bovine heart and cyclic adenosine 3',5'-monophosphate (CAMP)were purchased from Boehringer-Mannheim, papaverine and theophylline were from Sigma Chemical Co. 
EnzymeAssay
Bovine heart CAMP-PDE activity was measured as follows: The reaction mixture contained in a final volume of 1.0 ml, Tris-HCl buffer (pH7.0) 40him, MgSO4 2mM, CAMP 0.6mMas a substrate and the enzyme 7.5mU/ml. The reaction was started by adding the substrate. Incubation was carried out 30°C for 30 minutes, and the reaction was terminated by adding 0.1ml of 55% perchloric acid, and the mixture was centrifuged at 3000 rpm for 10 minutes. The reaction product, 5'-AMP in the supernatant, was analyzed with HPLC. The HPLC was performed on a reversed phase silica gel column (1) were obtained in pale yellow prism by recrystallization from MeOH.The crystal was mounted on a Mac Science MXC18 diffractometer with graphite-monochromated Cu Ka radiation (2= 1.5418A). Crystal structure was solved by direct method with SIR922), and refined by full-matrix leastsquares method with anisotropic thermal parameters for all non-H atoms and isotropic thermal parameters for all H atoms. Final R values was 0.032. 
Results and Discussion Production, Isolation and Purification
The strain of Sporormiella sp. M5032 was isolated from bovine excrement. This strain was cultured in Erlenmeyer flasks at 26°C for 3 days on a rotary shaker to produce the inhibitor, sporostatin (1) . The inhibitor was presents in the culture filtrate (9 liters) which was separated by centrifugation. The inhibitor was extracted with EtOAc at pH 2, and dried with anhydrous Na2SO4.The EtOAcextract was concentrated to a crude powder (ca. 700mg) in vacuo. The crude material was chromatographed on a silica gel column eluted with CHC13-EtOAc (10: 1). The active fractions were collected and concentrated, in vacuo, to a colorless amorphous powder (230mg). This powder was dissolved in
MeOH and crystallized to obtain pale yellow unaggregated crystals of sporostatin (1, 130mg NOV. 1997 Structure Elucidation The molecular formula of sporostatin (1) XH and 13C NMRspectral data in DMSO-d6 are described in Table 2 . The assignments were made on the basis of WH COSY, "C^H COSY, HMBCand NOESYwith the 2D NMRexperiments.
The XH NMR spectrum of 1 exhibited one secondary methyl group, two methylenes and one methine protons attached to saturated carbons, and four olefinic protons and two phenolic hydroxyls. In the low field region of the 1H NMRspectrum, the signals of two phenolic hydroxyl protons (7-OH: 8 13.61 (hydrogen bonded) and 5-OH: 5 10.74) and four aromatic protons (5 6.91, 6.32, 6.24 and 5.93) were observed. These four methines are assigned to 10-H, 4-H, 6-H and ll-H, respectively. The geometrical configuration of the olefinic bonds were established to be 10E by the vicinal coupling constant
CAo-ii=16-5Hz).
In the NOE experiments, 12-Ha observed NOE to 14-CH3 and 10-H, thereby indicated that these protons exist in the same plane. Onthe other hand, 12-Hb observed NOEto 13-H and ll-H. From these results, the structure of sporostatin (1) was determined as shown in Fig. 1 . The 13C NMRand other spectroscopic data mentioned above support the conclusion. Proton number, multiplicity and coupling constants (Hz) are in parentheses.
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The structure of 1 was finally determined by X-ray crystallography, but the absolute stereochemistry was not determined. The cell parameters, data collections and refinement details for 1 are summarized in Table 3 . Fig.  2 shows the ORTEP view of molecular structure of sporostatin (1) .
A variety of compoundsproduced by microorganism have been found to inhibit cyclic adenosine B'^'-monophosphate phosphodiesterase (CAMP-PDE), including reticulol3), PDE-I and II4), acylpeptides5), terferol6), griseolic acid7), KS-501 and KS-5028) and TPI compounds9). Sporostatin (1) was identified as a novel 10-memberedmacrolide derivatve with inhibitory activities against CAMP-PDE.
Biological Activity Inhibitory activities of sporostatin (1) against CAMPPDEfrom bovine heart expressed in terms of 50%in-hibition (IC50) was 41 /xg/ml, and it was noncompetitive againt CAMP. In the same condition, theophylline 
